Controversial Johnson & Johnson Talc Settlement Criticized by Former FDA Head

Controversial Johnson & Johnson Talc Settlement Criticized by Former FDA Head
1 month ago

In a significant development surrounding the long-standing litigation involving Johnson & Johnson (J&J) and its talc products, former FDA Commissioner, Dr. Scott Gottlieb, has expressed strong disapproval of the recent settlement reached by the company. This settlement is purportedly aimed at resolving thousands of lawsuits that allege a link between J&J's talc-based products and cancer, specifically ovarian cancer.

Continue reading
Bankruptcy Negotiations Heat Up: J&J's Talc Deal Faces Rejection from Holdouts

Bankruptcy Negotiations Heat Up: J&J's Talc Deal Faces Rejection from Holdouts
2 months ago

In a significant twist within the ongoing legal saga surrounding Johnson & Johnson's talc powder products, a group of objectors has risen to prominently challenge the company’s proposed $8.9 billion settlement aimed at resolving claims related to cancer risks associated with its talc products. The objection comes during the company's bankruptcy proceedings, where J&J has sought to establish a trust fund to compensate thousands of claimants alleging health issues linked to talc use.

Continue reading
J&J's $8.2 Billion Talc Settlement Faces Crucial January Assessment

J&J's $8.2 Billion Talc Settlement Faces Crucial January Assessment
5 months ago

In a pivotal development for Johnson & Johnson, the company’s monumental $8.2 billion settlement over claims related to its talc-based products is set to undergo a significant evaluation in January. This legal maneuver comes on the heels of extensive allegations that J&J’s talcum powder has been linked to cancer, resulting in a slew of lawsuits against the healthcare giant.

Continue reading
J&J Talc Settlement Under Fire: Allegations of Vote Buying Surface

J&J Talc Settlement Under Fire: Allegations of Vote Buying Surface
6 months ago

In a dramatic turn of events surrounding Johnson & Johnson’s (J&J) ongoing talc litigation, certain holdouts in a massive bankruptcy settlement have leveled serious accusations against the pharmaceutical giant. They claim that J&J has engaged in unethical practices aimed at swaying votes in favor of its proposed $8.9 billion settlement aimed at resolving thousands of claims related to its talc-based products.

Continue reading